QuadMedicine, Inc. (KOSDAQ:464490)

South Korea · Delayed Price · Currency is KRW

4,900.00

+30.00 (0.62%)

At close: Sep 3, 2026

QuadMedicine Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-10,108	-6,931	-4,968	-9,759
Depreciation & Amortization	3,521	3,296	3,153	2,071
Loss (Gain) From Sale of Assets	16.34	16.34	-	-
Stock-Based Compensation	116.66	281.42	608.42	1,456
Other Operating Activities	-190.9	-69.88	-128.87	40.43
Change in Accounts Receivable	-2,382	-706.73	-1,082	-6.41
Change in Other Net Operating Assets	3,289	-433.43	3,490	7,957
Operating Cash Flow	-5,748	-4,547	1,072	1,760
Operating Cash Flow Growth	-	-	-39.09%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Capital Expenditures	-3,977	-2,191	-3,286	-11,817
Sale (Purchase) of Intangibles	-240.41	-224.45	-218.8	-95.1
Investment in Securities	-11,499	-1,000	-10	4,760
Other Investing Activities	-133.42	-120.28	66.23	-134.66
Investing Cash Flow	-16,572	-4,313	-3,449	-7,286

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Short-Term Debt Issued	-	-	500	-
Long-Term Debt Issued	-	-	800	5,800
Total Debt Issued	1,500	-	1,300	5,800
Long-Term Debt Repaid	-	-357.49	-313.44	-271.52
Net Debt Issued (Repaid)	503.39	-357.49	986.56	5,528
Issuance of Common Stock	25,391	25,789	7,000	537.1
Other Financing Activities	-	-	74.04	196.28
Financing Cash Flow	25,895	25,431	8,061	6,262

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Foreign Exchange Rate Adjustments	158.4	-327.15	129.9	20.89
Net Cash Flow	3,733	16,244	5,814	757.16

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-9,725	-6,738	-2,214	-10,056
Free Cash Flow Growth	-	-	-	-
Free Cash Flow Margin	-136.15%	-62.98%	-23.80%	-993.97%
Free Cash Flow Per Share	-912.70	-701.66	-253.98	-1164.44
Levered Free Cash Flow	-6,673	-6,805	-2,182	-
Unlevered Free Cash Flow	-6,459	-6,587	-1,951	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash Interest Paid	351.27	352.04	368.76	64.9
Cash Income Tax Paid	11.59	9.25	-17.81	4.46
Change in Working Capital	900.67	-1,140	2,408	7,951